Innovative nanotechnologies for the delivery of oligonucleotides and siRNA
- 30 November 2006
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 60 (9) , 607-620
- https://doi.org/10.1016/j.biopha.2006.07.093
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Gene therapy: The good, the bad, and the uglySurgery, 2005
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004
- RNA Interference in Mammalian Cells by Chemically-Modified RNABiochemistry, 2003
- EWS Fli-1 Antisense Nanocapsules Inhibits Ewing Sarcoma-Related Tumor in MiceBiochemical and Biophysical Research Communications, 2000
- Effect of TNF-α Antisense Oligomers on Cytokine Production by Primary Murine Alveolar MacrophagesAntisense and Nucleic Acid Drug Development, 1998
- Morpholino and Phosphorothioate Antisense Oligomers Compared in Cell-Free and In-Cell SystemsAntisense and Nucleic Acid Drug Development, 1997
- Entry of animal viruses and macromolecules into cellsFEBS Letters, 1994
- Transport of oligonucleotides across natural and model membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1994
- PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rulesNature, 1993
- Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and seraLife Sciences, 1991